✦ LIBER ✦

Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: Comparison with non-injecting drug users

✍ Scribed by Basu, Debasish; Kumar, Vineet; Sharma, Arun Kumar; Barnwal, Pawan Kumar; Mattoo, Surendra Kumar

Book ID: 123029305
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 153 KB
Volume: 6
Category: Article
ISSN: 1876-2018
DOI: 10.1016/j.ajp.2012.08.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

813 HEPATITIS C VIRUS-SPECIFIC CELLULAR

813 HEPATITIS C VIRUS-SPECIFIC CELLULAR IMMUNITY DOES NOT PROTECT AGAINST FUTURE HCV INFECTION IN ANTI-HCV NEGATIVE INJECTING DRUG USERS

✍ R. Sacks-Davis; C. Aitken; P. Higgs; S. Moneer; J. Flynn; V. Suppiah; L. Tracy; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Epidemiology of hepatitis C virus in inj

Epidemiology of hepatitis C virus in injecting drug users in england and wales: implications for HCV drug therapy

✍ A. Judd; M. Hickman; G.V. Stimson; V.D. Hope; O. Gill; J.V. Parry 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Prevalence of hepatitis B virus and risk

Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users

✍ Renata C. Ferreira; Fabiana P. Rodrigues; Sheila A. Teles; Carmen L.R. Lopes; An 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract Non‐injecting drug users are at high‐risk for acquiring hepatitis B virus (HBV), although the factors contributing to this increased risk are not known. In the present study, the overall and occult HBV infection prevalence rates were determined in a large population of non‐injecting dru

Low perceived benefits and self-efficacy

Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users

✍ Joseph Cox; Prithwish De; Carole Morissette; Claude Tremblay; Randolph Stephenso 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Health-related quality of life in active

✍ Olav Dalgard; Atle Egeland; Kjell Skaug; Kostas Vilimas; Tore Steen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

This study assessed the effect of chronic hepatitis C virus (HCV) infection on the healthrelated quality of life (HRQOL) of injecting drug users, comparing the HRQOL of injecting drug users with and without chronic HCV infection. The study included 199 injecting drug users of more than 18 years of a

P.18.4 PREVALENCE AND MANAGEMENT OF HEPA

P.18.4 PREVALENCE AND MANAGEMENT OF HEPATITIS C VIRUS (HCV) INFECTION IN A POPULATION OF INJECTING DRUG USERS (IDUS) IN ROME, ITALY

✍ Nosotti, L.; Testa, R.; Leonardi, C.; Mirisola, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 56 KB